ABSTRACT
OBJECTIVE: Prenatal tracheal occlusion (TO) promotes lung growth and is applied clinically in fetuses with congenital diaphragmatic hernia (CDH). Limited data are available regarding the effect of duration versus timepoint of TO. Our objective was to document the impact of TO on lung development in the near-term period in rats with nitrofen-induced CDH. METHOD: Nitrofen was administered on embryonic day (ED)9 and fetal TO was performed on ED18.5, 19, or 20 (term = ED22). Sham-operated and untouched littermates served as controls. Lungs were harvested in 0.5-day steps and only fetuses with a left-sided CDH were included in further analyses. Healthy fetuses provided a reference for normal near-term lung development. RESULTS: Duration of TO in the nitrofen rat model for CDH predicts lung growth in terms of lung-body-weight ratio as well as an increased mRNA level of the proliferation marker Ki67. Longer TO also induced a more complex airway architecture. The timepoint of TO was not predictive of lung growth. CONCLUSION: In the nitrofen rat model of CDH, a longer period of TO leads to enhanced lung growth and more refined airway architecture.
Subject(s)
Airway Obstruction , Hernias, Diaphragmatic, Congenital , Female , Pregnancy , Animals , Rats , Phenyl Ethers/toxicity , Lung , Cell ProliferationABSTRACT
Lung hypoplasia in congenital diaphragmatic hernia (CDH) is a life-threatening birth defect. Severe cases can be offered tracheal occlusion to boost prenatal lung development, although defining those to benefit remains challenging. Metabonomics of (1)H NMR spectra collected from amniotic fluid (AF) can identify general changes in diseased versus healthy fetuses. AF embodies lung secretions and hence might contain pulmonary next to general markers of disease in CDH fetuses. AF from 81 healthy and 22 CDH fetuses was collected. NMR spectroscopy was performed at 400 MHz to compare AF from fetuses with CDH against controls. Several advanced feature extraction methods based on statistical tests that explore spectral variability, similarity, and dissimilarity were applied and compared. This resulted in the identification of 30 spectral regions, which accounted for 80% variability between CDH and controls. Combination with automated classification discriminates AF from CDH versus healthy fetuses with up to 92% accuracy. Within the identified spectral regions, isoleucine, leucine, valine, pyruvate, GABA, glutamate, glutamine, citrate, creatine, creatinine, taurine, and glucose were the most concentrated metabolites. As the metabolite pattern of AF changes with fetal development, we have excluded metabolites with a high age-related variability and repeated the analysis with 12 spectral regions, which has resulted in similar classification accuracy. From this analysis, it was possible to distinguish between AF from CDH fetuses versus healthy controls independent of gestational age.
Subject(s)
Amniotic Fluid/chemistry , Hernias, Diaphragmatic, Congenital/diagnosis , Hernias, Diaphragmatic, Congenital/metabolism , Metabolome , Case-Control Studies , Female , Fetus , Gestational Age , Hernias, Diaphragmatic, Congenital/pathology , Humans , Lung/metabolism , Lung/pathology , Magnetic Resonance Spectroscopy/methods , Magnetic Resonance Spectroscopy/statistics & numerical data , Male , Prenatal Diagnosis , Principal Component AnalysisABSTRACT
OBJECTIVE: To explore the psychosocial impact of invasive fetal therapy (FT). METHODS: We studied 100 consecutive patients scheduled for invasive FT. Contemporary controls were women undergoing (1) invasive prenatal diagnosis (AC/CVS) and (2) first trimester risk assessment of aneuploidy (NT), and (3) women who declined the latter (CTR). Prior to the procedure, participants completed the Beck Depression Inventory II, the State-Trait Anxiety Inventory, the Dyadic Adjustment Scale and a questionnaire specifically designed to evaluate the process preceding the intervention. RESULTS: Thirty-five percent of women in the FT group had mild to severe depressive symptoms, and 30% showed high levels of state anxiety. Mean state anxiety was significantly higher in women facing invasive as compared to non-invasive procedures. Trait anxiety levels and relationship scores were comparable across all groups. FT patients were more satisfied with the information and support given, whereas women in the NT group felt a greater degree of self-determination and contentedness with the choices they made. CONCLUSION: Pregnant women awaiting invasive prenatal diagnosis and FT face higher levels of state anxiety than women undergoing non-invasive procedures. Traits of depression and high state anxiety are found in at least one third of women undergoing FT.
Subject(s)
Fetal Therapies/psychology , Adult , Anxiety/epidemiology , Belgium/epidemiology , Depression/epidemiology , Female , Humans , Middle Aged , Pregnancy , Prenatal Diagnosis/psychology , Prospective Studies , Risk Assessment , Young AdultABSTRACT
OBJECTIVE: Prenatal tracheal occlusion (TO) promotes lung growth and is applied clinically in fetuses with severe congenital diaphragmatic hernia. Limited data are available regarding the effect of duration of TO on lung development. Our objective was to evaluate the effects of long (2 and 2.5 days) versus short (1 day) TO on lung development in rats with nitrofen-induced diaphragmatic hernia. METHOD: Nitrofen was administered on embryonic day (ED) 9 and fetal TO performed either on ED18.5, 19 or 20 (term = 22 days). Sham-operated and untouched littermates served as controls. On ED21, lungs were harvested and only fetuses with a left-sided diaphragmatic defect were included in further analyses. RESULTS: Lung-body-weight ratio incrementally increased with the duration of TO. Increased proliferation following long TO was confirmed by immunohistochemistry and qRT-PCR for the proliferation marker Ki-67. Irrespective of duration, TO induced more complex airway architecture. Medial wall thickness of pulmonary arteries was thinner after long rather than short TO. CONCLUSION: In the nitrofen rat model of congenital diaphragmatic hernia, a longer period of TO leads to enhanced lung growth and less muscularized pulmonary arteries.
Subject(s)
Fetal Diseases/surgery , Hernias, Diaphragmatic, Congenital , Lung/embryology , Trachea/surgery , Animals , Cell Proliferation/drug effects , Disease Models, Animal , Female , Fetus/abnormalities , Fetus/surgery , Gestational Age , Herbicides/toxicity , Hernia, Diaphragmatic/chemically induced , Hernia, Diaphragmatic/pathology , Hernia, Diaphragmatic/surgery , Lung/drug effects , Lung/pathology , Organ Size , Phenyl Ethers/toxicity , Pregnancy , Rats , Rats, Wistar , Time FactorsABSTRACT
OBJECTIVE: Iatrogenic preterm prelabor rupture of membranes (iPPROM; <37 weeks of gestation) is a major complication of fetal surgery. Little information is available about risk factors and incidence. METHODS: We systematically reviewed reported iPPROM rates, gestational age at delivery and fetal survival after representative minimally invasive antenatal procedures. RESULTS: A total of 1,146, 36 and 194 cases with mean iPPROM rates of 27, 31 and 26% were included for placental laser in twin-twin transfusion syndrome, shunting in lower urinary tract obstruction and interventions for twin-reversed arterial perfusion, respectively. In the statistical analysis, the maximum diameter of the instrument predicted iPPROM rate and was significantly related to gestational age at birth as well as fetal survival. Information on duration of the respective procedures was scarce and did not allow for meaningful analysis. CONCLUSIONS: iPPROM occurs in about 30% of cases treated by minimally invasive fetal surgery. The maximum diameter of the instrument explains iPPROM rate, gestational age at birth and fetal survival. Great variations in the reporting of iPPROM make data analysis difficult.
Subject(s)
Fetal Membranes, Premature Rupture/etiology , Fetoscopy/adverse effects , Adult , Analysis of Variance , Female , Fetal Membranes, Premature Rupture/epidemiology , Fetofetal Transfusion/surgery , Gestational Age , Humans , Infant, Newborn , Infant, Premature , Minimally Invasive Surgical Procedures/adverse effects , Placenta/surgery , Pregnancy , Survival Analysis , Urologic Diseases/embryology , Urologic Diseases/surgeryABSTRACT
About 30% of monochorionic twin pregnancies are complicated by twin-to-twin transfusion syndrome (TTTS), isolated discordant growth, twin anemia-polycythemia sequence, congenital defects or intrauterine demise. About 15% will be eligible for invasive fetal therapy, either fetoscopic laser treatment for TTTS or fetoscopic or ultrasound-guided umbilical cord coagulation for a severe congenital defect in one twin or severe discordant growth with imminent demise of the growth-restricted twin. Ultrasound examination in the first and early second trimester can differentiate the monochorionic twins at high risk for adverse outcome from those likely to be uneventful, which may be useful for patient counselling and planning of care.
Subject(s)
Chorion/diagnostic imaging , Fetal Diseases/diagnostic imaging , Fetofetal Transfusion/diagnostic imaging , Pregnancy Complications, Hematologic/diagnostic imaging , Twins, Monozygotic , Amniotic Fluid/diagnostic imaging , Chorion/physiopathology , Female , Fetal Diseases/epidemiology , Fetal Diseases/physiopathology , Fetofetal Transfusion/epidemiology , Fetofetal Transfusion/physiopathology , Humans , Pregnancy , Pregnancy Complications, Hematologic/epidemiology , Pregnancy Complications, Hematologic/physiopathology , Pregnancy Trimester, First , Pregnancy Trimester, Second , Risk Factors , UltrasonographyABSTRACT
An increasing number of fetal anomalies are being diagnosed prior to birth, some of them amenable to fetal surgical intervention. We discuss the current clinical status and recent advances in endoscopic and open surgical interventions. In Europe, fetoscopic interventions are widely embraced, whereas the uptake of open fetal surgery is much less. The indications for each access modality are different, hence they cannot substitute each other. Although the stage of technical experimentation is over, most interventions remain investigational. Today there is level I evidence that fetoscopic laser surgery for twin-to-twin transfusion syndrome is the preferred therapy, but this operation actually takes place on the placenta. In terms of surgery on the fetus, an increasingly frequent indication is severe congenital diaphragmatic hernia as well as myelomeningocele. Overall maternal safety is high, but rupture of the membranes and preterm delivery remain a problem. The increasing application of fetal surgery and its mediagenicity has triggered the interest to embark on fetal surgical therapy, although the complexity as well as the overall rare indications are a limitation to sufficient experience on an individual basis. We plead for increased exchange between high volume units and collaborative studies; there may also be a case for self-regulation. Inclusion of patients into trials whenever possible should be encouraged rather than building up casuistic experience.
Subject(s)
Congenital Abnormalities/surgery , Fetal Diseases/surgery , Fetoscopy/methods , Fetus/surgery , Prenatal Diagnosis/methods , Anastomosis, Surgical/methods , Clinical Trials as Topic , Female , Fetofetal Transfusion/surgery , Fetoscopy/standards , Hernia, Diaphragmatic/surgery , Hernias, Diaphragmatic, Congenital , Humans , Laser Therapy , Meningomyelocele/surgery , Placenta/surgery , Pregnancy , Twins, MonozygoticABSTRACT
Congenital diaphragmatic hernia (CDH) can be associated with genetic or structural anomalies with poor prognosis. In isolated cases, survival is dependent on the degree of lung hypoplasia and liver position. Cases should be referred in utero to tertiary care centers familiar with this condition both for prediction of outcome as well as timed delivery. The best validated prognostic indicator is the lung area to head circumference ratio. Ultrasound is used to measure the lung area of the index case, which is then expressed as a proportion of what is expected normally (observed/expected LHR). When O/E LHR is < 25% survival chances are < 15%. Prenatal intervention, aiming to stimulate lung growth, can be achieved by temporary fetal endoscopic tracheal occlusion (FETO). A balloon is percutaneously inserted into the trachea at 26-28 weeks, and reversal of occlusion is planned at 34 weeks. Growing experience has demonstrated the feasibility and safety of the technique with a survival rate of about 50%. The lung response to, and outcome after FETO, is dependent on pre-existing lung size as well gestational age at birth. Early data show that FETO does not increase morbidity in survivors, when compared to historical controls. Several trials are currently under design.
Subject(s)
Fetoscopy , Hernia, Diaphragmatic/surgery , Hernias, Diaphragmatic, Congenital , Lung/abnormalities , Ultrasonography, Prenatal , Female , Fetal Organ Maturity , Hernia, Diaphragmatic/diagnostic imaging , Humans , Lung/diagnostic imaging , Lung/surgery , Pregnancy , Treatment OutcomeABSTRACT
For cellular-invasive processes during a variety of physio- and pathophysiological events, including cancer, a fine-tuned balance between the formation and loosening of cell adhesive contacts has to occur, implicating the action of pericellular proteases; among those, the serine protease, urokinase-type plasminogen activator (uPA), its inhibitor PAI-1, and its cellular receptor uPA-R (CD87). Apart from its proteolytic functions, the uPA system is endowed with properties affecting the proliferative, adhesive, and migratory cellular phenotype. These events depend on signal transduction pathways known to be activated downstream of uPA/uPA-R cell surface interaction and require physical and functional cooperation and crosstalk with cell adhesion and signaling receptors of the integrin superfamily. This chapter focuses on the description of several in vitro cell biological assay systems suitable for studying (cancer) cell behavior with respect to cell proliferation, cell adhesion, and cell motility, e.g., as a function of uPA-R/integrin-mediated effects.
Subject(s)
Cell Adhesion/physiology , Cell Movement/physiology , Cell Proliferation , Neoplasms/metabolism , Receptors, Cell Surface/metabolism , Signal Transduction/physiology , Urokinase-Type Plasminogen Activator/metabolism , Animals , Biological Assay/methods , Microscopy, Video , Neoplasms/physiopathology , Plasminogen Activator Inhibitor 1/metabolism , Receptors, Urokinase Plasminogen ActivatorABSTRACT
We have recently described that integrin alphavbeta3 upon interaction with its major extracellular matrix ligand vitronectin induces adhesion, motility, and proliferation of human ovarian cancer cells. Due to the important function of alphavbeta3 in cancer cell biology, it has been the effort of many scientific approaches to specifically target alphavbeta3-mediated cell adhesion and tumorbiological effects arising thereof by synthetic integrin antagonists. More recently, proteins of the ADAM family have been recognized as naturally occurring integrin ligands. Among those, human ADAM15 which encompasses the integrin binding RGD motif was shown to interact with integrin alphavbeta3. Thus, we investigated in human ovarian OV-MZ-6 cancer cells, expressing both ADAM15 and alphavbeta3, whether ADAM15 might affect alphavbeta3-mediated tumorbiological effects. We stably (over)expressed ADAM15 or its extracellular domain in OV-MZ-6 cells as well as respective ADAM15 mutants containing the tripeptide SGA instead of RGD. Cells (over)expressing ADAM15-RGD exhibited a significantly reduced alphavbeta3-mediated adhesion to vitronectin. Also, a significant time-dependent decline in numbers of cells cultivated on vitronectin was noticed. This effect was found to be rather due to impaired alphavbeta3-mediated cell adhesion than decreased cell proliferation rates, since de novo DNA synthesis was not significantly altered by elevated ADAM15 expression. Moreover, a substantially decreased random cellular motility was noticed as a function of ADAM15 encompassing an intact RGD motif. In conclusion, our results point to a physiological role of ADAM15 as a natural binding partner of integrin alphavbeta3 thereby loosening tumor cell adhesion to the underlying matrix and regulating tumor cell migration and invasion.